Charles River Laboratories Acquires SAMDI Tech

FairJourney Biologics Acquires Charles River Laboratories' South San Francisco Facility

March 3, 2025

Biotechnology

FairJourney Biologics S.A. has acquired Charles River Laboratories' South San Francisco site (formerly Distributed Bio), including facilities, staff, assets and proprietary antibody libraries and yeast display technology. The acquisition expands FairJourney's antibody discovery and engineering capabilities and establishes a strategic presence in a major U.S. biotech hub to better serve biopharma customers.

SSI Diagnostica (Adelis) Acquires TECHLAB, Inc. from Pharos Capital

August 22, 2022

Medical Devices

SSI Diagnostica, a portfolio company of Adelis Equity, has acquired TECHLAB, Inc. from Pharos Capital Group. The acquisition combines SSI Diagnostica's global distribution and production capabilities with TECHLAB's U.S. R&D and manufacturing to grow the combined diagnostics business; TECHLAB will continue operating from its Virginia facilities and retain its management team and workforce.

Sentient Digital Acquires Maritime Surveillance Associates

January 13, 2025

Aerospace & Defense

Sentient Digital, Inc. (SDi) has acquired Maritime Surveillance Associates, Inc. (MSA), a developer of signal processing and mission reconstruction software for the U.S. Navy. The acquisition expands SDi's sonar and acoustics capabilities and supports its push into cloud-based advanced analytics, maritime security, and Foreign Military Sales (FMS).

SD Biosensor and SJL Partners Acquire Meridian Bioscience for $1.53B

July 7, 2022

Medical Devices

A consortium led by SD Biosensor and private equity firm SJL Partners agreed to acquire Meridian Bioscience in an all-cash transaction valued at approximately $1.53 billion ( $34.00 per share). The deal will take Meridian private and is intended to accelerate SD Biosensor's entry into the U.S. in-vitro diagnostics market while leveraging Meridian's U.S. distribution network and product portfolio.

Charles River Laboratories Acquires Cognate BioServices

February 17, 2021

Biotechnology

Charles River Laboratories agreed to acquire Cognate BioServices for approximately $875 million in cash, expanding Charles River's capabilities into the high-growth cell and gene therapy CDMO sector. Cognate, headquartered in Memphis, Tennessee with over 500 employees, will provide Charles River integrated cell and gene therapy development, testing, and CGMP manufacturing capabilities; the deal was expected to close by end of Q1 2021.

SSI Diagnostica (Adelis portfolio) Acquires CTK Biotech

August 26, 2020

Medical Devices

Adelis Equity Partners portfolio company SSI Diagnostica has acquired US-based CTK Biotech to create a global rapid diagnostics leader focused on respiratory and tropical disease tests. The deal combines SSI Diagnostica's Nordic IVD capabilities and distribution with CTK's product development and manufacturing (headquartered in San Diego with a manufacturing plant in Beijing), and triggers a CEO change and several board appointments.